Sensus Healthcare EBITDA Margin 2014-2025 | SRTS
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Sensus Healthcare (SRTS) over the last 10 years. The current EBITDA margin for Sensus Healthcare as of March 31, 2025 is .
| Sensus Healthcare EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $0.04B | $0.00B | 7.69% |
| 2024-12-31 | $0.04B | $0.01B | 21.43% |
| 2024-09-30 | $0.04B | $0.01B | 30.95% |
| 2024-06-30 | $0.04B | $0.01B | 24.32% |
| 2024-03-31 | $0.03B | $0.01B | 18.18% |
| 2023-12-31 | $0.03B | 0 | 0.00% |
| 2023-09-30 | $0.03B | $0.00B | -8.00% |
| 2023-06-30 | $0.03B | $0.00B | 6.67% |
| 2023-03-31 | $0.04B | $0.01B | 21.62% |
| 2022-12-31 | $0.04B | $0.02B | 34.09% |
| 2022-09-30 | $0.04B | $0.02B | 36.36% |
| 2022-06-30 | $0.04B | $0.01B | 34.15% |
| 2022-03-31 | $0.03B | $0.01B | 26.47% |
| 2021-12-31 | $0.03B | $0.00B | 14.81% |
| 2021-09-30 | $0.02B | $0.00B | -5.26% |
| 2021-06-30 | $0.02B | $0.00B | -20.00% |
| 2021-03-31 | $0.01B | $-0.01B | -45.45% |
| 2020-12-31 | $0.01B | $-0.01B | -70.00% |
| 2020-09-30 | $0.01B | $-0.01B | -42.86% |
| 2020-06-30 | $0.02B | $-0.01B | -27.78% |
| 2020-03-31 | $0.02B | $0.00B | -12.50% |
| 2019-12-31 | $0.03B | $0.00B | -7.41% |
| 2019-09-30 | $0.03B | $0.00B | -11.54% |
| 2019-06-30 | $0.03B | $0.00B | -7.69% |
| 2019-03-31 | $0.03B | $0.00B | -8.00% |
| 2018-12-31 | $0.03B | $0.00B | -3.85% |
| 2018-09-30 | $0.02B | $0.00B | -4.17% |
| 2018-06-30 | $0.02B | $0.00B | -8.70% |
| 2018-03-31 | $0.02B | $0.00B | -13.64% |
| 2017-12-31 | $0.02B | $0.00B | -15.00% |
| 2017-09-30 | $0.02B | $0.00B | -15.79% |
| 2017-06-30 | $0.02B | $0.00B | -11.76% |
| 2017-03-31 | $0.02B | $0.00B | -6.25% |
| 2016-12-31 | $0.02B | 0 | 0.00% |
| 2016-09-30 | $0.01B | 0 | 0.00% |
| 2016-06-30 | $0.01B | 0 | 0.00% |
| 2016-03-31 | $0.01B | 0 | 0.00% |
| 2015-12-31 | $0.01B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.087B | $0.042B |
| Sensus Healthcare, Inc. is a medical device company It specializes in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. The company's portfolio of treatment devices consists of the SRT-100(TM) and SRT-100 Vision(TM). Sensus Healthcare, Inc. is headquartered in Boca Raton, Florida. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $180.170B | 21.80 |
| Intuitive Surgical (ISRG) | United States | $179.421B | 74.37 |
| Edwards Lifesciences (EW) | United States | $47.608B | 31.58 |
| IDEXX Laboratories (IDXX) | United States | $46.009B | 52.87 |
| Alcon (ALC) | Switzerland | $43.988B | 29.73 |
| DexCom (DXCM) | United States | $34.921B | 52.39 |
| IQVIA Holdings (IQV) | United States | $32.562B | 18.40 |
| Mettler-Toledo (MTD) | United States | $26.309B | 31.29 |
| STERIS (STE) | Ireland | $22.554B | 24.84 |
| Waters (WAT) | United States | $17.797B | 25.11 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.385B | 0.00 |
| Hologic (HOLX) | United States | $14.480B | 15.66 |
| Sysmex ADR (SSMXY) | Japan | $10.386B | 29.46 |
| Penumbra (PEN) | United States | $9.845B | 72.42 |
| Masimo (MASI) | United States | $8.459B | 31.20 |
| Globus Medical (GMED) | United States | $7.236B | 17.24 |
| Glaukos (GKOS) | United States | $5.374B | 0.00 |
| Teleflex (TFX) | United States | $5.034B | 8.31 |
| Integer Holdings (ITGR) | United States | $3.810B | 19.01 |
| TransMedics (TMDX) | United States | $3.643B | 55.80 |
| PROCEPT BioRobotics (PRCT) | United States | $2.841B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.400B | 14.29 |
| Nihon Kohden (NHNKY) | Japan | $1.956B | 22.43 |
| Elekta AB (EKTAY) | Sweden | $1.903B | 17.10 |
| Veracyte (VCYT) | United States | $1.877B | 26.34 |
| Alphatec Holdings (ATEC) | United States | $1.568B | 0.00 |
| Artivion (AORT) | United States | $1.348B | 126.28 |
| Tandem Diabetes Care (TNDM) | United States | $1.110B | 0.00 |
| OPKO Health (OPK) | United States | $1.063B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.991B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.961B | 5.11 |
| SiBone (SIBN) | United States | $0.759B | 0.00 |
| IRadimed (IRMD) | United States | $0.742B | 37.66 |
| Beta Bionics (BBNX) | United States | $0.727B | 0.00 |
| AxoGen (AXGN) | United States | $0.601B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.540B | 8.40 |
| OrthoPediatrics (KIDS) | United States | $0.527B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.495B | 10.66 |
| Pacific Biosciences Of California (PACB) | United States | $0.447B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.445B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.434B | 10.08 |
| Delcath Systems (DCTH) | United States | $0.381B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.364B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.348B | 0.00 |
| RxSight (RXST) | United States | $0.324B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.298B | 0.00 |
| Neuronetics (STIM) | United States | $0.294B | 0.00 |
| NeuroPace (NPCE) | United States | $0.287B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.246B | 0.00 |
| 908 Devices (MASS) | United States | $0.244B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.236B | 14.30 |
| CVRx (CVRX) | United States | $0.215B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.200B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.178B | 0.00 |
| Inogen (INGN) | United States | $0.176B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.166B | 0.00 |
| LENSAR (LNSR) | United States | $0.156B | 0.00 |
| Accuray (ARAY) | United States | $0.151B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.123B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.120B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.113B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.109B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.094B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.085B | 0.00 |
| Hyperfine (HYPR) | United States | $0.079B | 0.00 |
| InspireMD (NSPR) | United States | $0.073B | 0.00 |
| Spectral AI (MDAI) | United States | $0.062B | 0.00 |
| Positron (POSC) | United States | $0.061B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.055B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.051B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.050B | 20.33 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.014B | 0.00 | |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 14.74 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |